 | • レポートコード：MRC2-11QY11433 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結腸がんのグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結腸がんの競争状況、市場シェア ・世界の結腸がん市場：種類別市場規模 2015年-2020年（手術、化学療法、放射線） ・世界の結腸がん市場：種類別市場規模予測 2021年-2026年（手術、化学療法、放射線） ・世界の結腸がん市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界の結腸がん市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米の結腸がん市場分析：米国、カナダ ・ヨーロッパの結腸がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結腸がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結腸がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結腸がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bedford Laboratories、Sanofi Aventis、Bayer、GlaxoSmithKline、Teva Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
Market Analysis and Insights: Global Colon Cancer Market
The global Colon Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Colon Cancer Scope and Market Size
Colon Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colon Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bedford Laboratories
Sanofi Aventis
Bayer
GlaxoSmithKline
Teva Pharmaceutical Industries
…
Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiation
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Colon Cancer Revenue
1.4 Market by Type
1.4.1 Global Colon Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Chemotherapy
1.4.4 Radiation
1.5 Market by Application
1.5.1 Global Colon Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Colon Cancer Market Perspective (2015-2026)
2.2 Global Colon Cancer Growth Trends by Regions
2.2.1 Colon Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colon Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Colon Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Colon Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Colon Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Colon Cancer Players by Market Size
3.1.1 Global Top Colon Cancer Players by Revenue (2015-2020)
3.1.2 Global Colon Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Colon Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Colon Cancer Market Concentration Ratio
3.2.1 Global Colon Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Colon Cancer Revenue in 2019
3.3 Colon Cancer Key Players Head office and Area Served
3.4 Key Players Colon Cancer Product Solution and Service
3.5 Date of Enter into Colon Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Colon Cancer Historic Market Size by Type (2015-2020)
4.2 Global Colon Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Colon Cancer Market Size by Application (2015-2020)
5.2 Global Colon Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colon Cancer Market Size (2015-2020)
6.2 Colon Cancer Key Players in North America (2019-2020)
6.3 North America Colon Cancer Market Size by Type (2015-2020)
6.4 North America Colon Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Colon Cancer Market Size (2015-2020)
7.2 Colon Cancer Key Players in Europe (2019-2020)
7.3 Europe Colon Cancer Market Size by Type (2015-2020)
7.4 Europe Colon Cancer Market Size by Application (2015-2020)
8 China
8.1 China Colon Cancer Market Size (2015-2020)
8.2 Colon Cancer Key Players in China (2019-2020)
8.3 China Colon Cancer Market Size by Type (2015-2020)
8.4 China Colon Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Colon Cancer Market Size (2015-2020)
9.2 Colon Cancer Key Players in Japan (2019-2020)
9.3 Japan Colon Cancer Market Size by Type (2015-2020)
9.4 Japan Colon Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Colon Cancer Market Size (2015-2020)
10.2 Colon Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Colon Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Colon Cancer Market Size by Application (2015-2020)
11 India
11.1 India Colon Cancer Market Size (2015-2020)
11.2 Colon Cancer Key Players in India (2019-2020)
11.3 India Colon Cancer Market Size by Type (2015-2020)
11.4 India Colon Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Colon Cancer Market Size (2015-2020)
12.2 Colon Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Colon Cancer Market Size by Type (2015-2020)
12.4 Central & South America Colon Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bedford Laboratories
13.1.1 Bedford Laboratories Company Details
13.1.2 Bedford Laboratories Business Overview
13.1.3 Bedford Laboratories Colon Cancer Introduction
13.1.4 Bedford Laboratories Revenue in Colon Cancer Business (2015-2020))
13.1.5 Bedford Laboratories Recent Development
13.2 Sanofi Aventis
13.2.1 Sanofi Aventis Company Details
13.2.2 Sanofi Aventis Business Overview
13.2.3 Sanofi Aventis Colon Cancer Introduction
13.2.4 Sanofi Aventis Revenue in Colon Cancer Business (2015-2020)
13.2.5 Sanofi Aventis Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Colon Cancer Introduction
13.3.4 Bayer Revenue in Colon Cancer Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Colon Cancer Introduction
13.4.4 GlaxoSmithKline Revenue in Colon Cancer Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Details
13.5.2 Teva Pharmaceutical Industries Business Overview
13.5.3 Teva Pharmaceutical Industries Colon Cancer Introduction
13.5.4 Teva Pharmaceutical Industries Revenue in Colon Cancer Business (2015-2020)
13.5.5 Teva Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Colon Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Colon Cancer Revenue
Table 3. Ranking of Global Top Colon Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Colon Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation
Table 8. Global Colon Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Colon Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Colon Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Colon Cancer Market Share by Regions (2015-2020)
Table 12. Global Colon Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Colon Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Colon Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Colon Cancer Players
Table 19. Global Colon Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Colon Cancer Market Share by Players (2015-2020)
Table 21. Global Top Colon Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer as of 2019)
Table 22. Global Colon Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Colon Cancer Product Solution and Service
Table 25. Date of Enter into Colon Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Colon Cancer Market Size Share by Type (2015-2020)
Table 29. Global Colon Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Colon Cancer Market Size Share by Application (2015-2020)
Table 31. Global Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Colon Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Colon Cancer Market Share (2019-2020)
Table 35. North America Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Colon Cancer Market Share by Type (2015-2020)
Table 37. North America Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Colon Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Colon Cancer Market Share (2019-2020)
Table 41. Europe Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Colon Cancer Market Share by Type (2015-2020)
Table 43. Europe Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Colon Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Colon Cancer Market Share (2019-2020)
Table 47. China Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Colon Cancer Market Share by Type (2015-2020)
Table 49. China Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Colon Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Colon Cancer Market Share (2019-2020)
Table 53. Japan Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Colon Cancer Market Share by Type (2015-2020)
Table 55. Japan Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Colon Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Colon Cancer Market Share (2019-2020)
Table 59. Southeast Asia Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Colon Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Colon Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Colon Cancer Market Share (2019-2020)
Table 65. India Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Colon Cancer Market Share by Type (2015-2020)
Table 67. India Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Colon Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Colon Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Colon Cancer Market Share (2019-2020)
Table 71. Central & South America Colon Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Colon Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Colon Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Colon Cancer Market Share by Application (2015-2020)
Table 75. Bedford Laboratories Company Details
Table 76. Bedford Laboratories Business Overview
Table 77. Bedford Laboratories Product
Table 78. Bedford Laboratories Revenue in Colon Cancer Business (2015-2020) (Million US$)
Table 79. Bedford Laboratories Recent Development
Table 80. Sanofi Aventis Company Details
Table 81. Sanofi Aventis Business Overview
Table 82. Sanofi Aventis Product
Table 83. Sanofi Aventis Revenue in Colon Cancer Business (2015-2020) (Million US$)
Table 84. Sanofi Aventis Recent Development
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Product
Table 88. Bayer Revenue in Colon Cancer Business (2015-2020) (Million US$)
Table 89. Bayer Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Colon Cancer Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Teva Pharmaceutical Industries Company Details
Table 96. Teva Pharmaceutical Industries Business Overview
Table 97. Teva Pharmaceutical Industries Product
Table 98. Teva Pharmaceutical Industries Revenue in Colon Cancer Business (2015-2020) (Million US$)
Table 99. Teva Pharmaceutical Industries Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colon Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Features
Figure 5. Global Colon Cancer Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Colon Cancer Report Years Considered
Figure 10. Global Colon Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Colon Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Colon Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Colon Cancer Market Share by Players in 2019
Figure 15. Global Top Colon Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Colon Cancer Revenue in 2019
Figure 17. North America Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Colon Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
結腸・直腸がんの世界市場（～2026年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Colon & Rectal Carcinoma Scope and Market Size Colon & Rectal Car…- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 上咽頭がんの世界市場（～2026年） Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus. Increasing geriatric population, rise in con…
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…